AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Nov 13, 2015
30016_dirs_2015-11-13_5eddd1c0-2968-4155-93a3-c99de90359a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-11-13
Reporting Person: AYERS JONATHAN W (Director, Chairman, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-13 | Common Stock | M | 20174 | $17.185 | Acquired | 961640 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-13 | Non-Qualified Stock Option (right-to-buy) | $17.185 | M | 20174 | Disposed | 2016-02-13 | Common Stock (20174) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 98000 | Indirect |
Footnotes
F1: Includes 99 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2015.
F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 15,999 shares on February 14, 2010 and February 14, 2013, 16,000 shares on February 14, 2011 and February 14, 2012, and the remaining 13,091 shares on February 14, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F3: Not applicable.